Metropolitan Life Insurance Company (MetLife)’s Artivion AORT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,157	Closed	-$45.6K	–	147
2024 Q1	$45.6K	Hold	2,157	–	–	﹤0.01%	1450
2023 Q4	$38.6K	Hold	2,157	–	–	﹤0.01%	1587
2023 Q3	$32.7K	Hold	2,157	–	–	﹤0.01%	1632
2023 Q2	$37.1K	Hold	2,157	–	–	﹤0.01%	1606
2023 Q1	$28.3K	Sell	2,157 -522	-19%	-$6.67K	﹤0.01%	1714
2022 Q4	$32.5K	Hold	2,679	–	–	﹤0.01%	1744
2022 Q3	$37.1K	Hold	2,679	–	–	﹤0.01%	1656
2022 Q2	$50.6K	Hold	2,679	–	–	﹤0.01%	1503
2022 Q1	$57.3K	Sell	2,679 -9,550	-78%	-$184K	﹤0.01%	1523
2021 Q4	$249K	Hold	12,229	–	–	﹤0.01%	1870
2021 Q3	$273K	Hold	12,229	–	–	﹤0.01%	1849
2021 Q2	$347K	Buy	12,229 +384	+3%	+$10.5K	﹤0.01%	1758
2021 Q1	$267K	Hold	11,845	–	–	﹤0.01%	1815
2020 Q4	$280K	Hold	11,845	–	–	﹤0.01%	1718
2020 Q3	$219K	Hold	11,845	–	–	﹤0.01%	1712
2020 Q2	$227K	Hold	11,845	–	–	﹤0.01%	1714
2020 Q1	$200K	Buy	11,845 +231	+2%	+$5.93K	﹤0.01%	1587
2019 Q4	$315K	Sell	11,614 -542	-4%	-$13.3K	0.01%	1612
2019 Q3	$330K	Buy	12,156 +1,107	+10%	+$31.3K	0.01%	1546
2019 Q2	$331K	Hold	11,049	–	–	0.01%	1558
2019 Q1	$322K	Hold	11,049	–	–	0.01%	1584
2018 Q4	$314K	Hold	11,049	–	–	0.01%	1525
2018 Q3	$389K	Hold	11,049	–	–	0.01%	1545
2018 Q2	$308K	Buy	11,049 +449	+4%	+$11.3K	0.01%	1640
2018 Q1	$213K	Hold	10,600	–	–	﹤0.01%	1853
2017 Q4	$203K	Buy	+10,600	New	+$212K	﹤0.01%	1900
2017 Q3	–	Sell	-24,366	Closed	-$486K	–	2463
2017 Q2	$486K	Hold	24,366	–	–	﹤0.01%	1714
2017 Q1	$406K	Hold	24,366	–	–	﹤0.01%	1796
2016 Q4	$467K	Hold	24,366	–	–	﹤0.01%	1781
2016 Q3	$428K	Hold	24,366	–	–	﹤0.01%	1799
2016 Q2	$288K	Hold	24,366	–	–	﹤0.01%	2083
2016 Q1	$262K	Hold	24,366	–	–	﹤0.01%	2002
2015 Q4	$263K	Buy	24,366 +3,563	+17%	+$37.3K	﹤0.01%	2049
2015 Q3	$202K	Sell	20,803 -2,972	-13%	-$31K	﹤0.01%	2272
2015 Q2	$268K	Sell	23,775 -3,108	-12%	-$33K	﹤0.01%	2196
2015 Q1	$279K	Sell	26,883 -273	-1%	-$3.01K	﹤0.01%	1880
2014 Q4	$308K	Hold	27,156	–	–	﹤0.01%	2108
2014 Q3	$268K	Hold	27,156	–	–	﹤0.01%	2168
2014 Q2	$243K	Hold	27,156	–	–	﹤0.01%	2364
2014 Q1	$270K	Hold	27,156	–	–	﹤0.01%	2258
2013 Q4	$301K	Hold	27,156	–	–	﹤0.01%	2175
2013 Q3	$190K	Hold	27,156	–	–	﹤0.01%	2461
2013 Q2	$170K	Buy	+27,156	New	+$166K	﹤0.01%	2446

Other funds holding AORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AORT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Artivion (AORT) in Q2 2024, closing a stake of 2,157 shares — an estimated $45.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AORT in Q2 2013 and held it in 43 quarters. The position peaked at $486K in Q2 2017. 163 funds tracked by Wall St. Rank hold AORT as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Artivion position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,157 Artivion shares in Q2 2024, an estimated $45.6K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Artivion in Q2 2013 and held it in 43 quarters.
Metropolitan Life Insurance Company (MetLife)'s Artivion position peaked at $486K in Q2 2017.
163 funds tracked by Wall St. Rank held Artivion as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.